CHUGAI PHARMABODY RESEARCH
Who is CHUGAI PHARMABODY RESEARCH?
Chugai Pharmabody Research (CPR) is a subsidiary of Chugai Pharmaceutical in Japan, a member of Roche group, dedicated to addressing unmet medical needs through antibody drug discovery using proprietary technologies.
Industry & Specialities
Others
Countries of Operation
Malaysia Singapore
Headquarters:
Singapore
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2012 (14 years)
Address:
3 BIOPOLIS DR; #07 -11 TO 16; SINGAPORE, SINGAPORE 138623, SG
Employees by Department
- IT / Product (4)
- Sales (3)
- The Rest (91)
- Total (98)
Key Decision Makers
Alicia Ang
Account Officer
Nurlin Naziha
Human Resources Officer
Dorinda Kioh
Safety Officer
Yan L
Data Scientist/Senior Scientist
Insight
Signals
At a glance- Operates in multiple countries
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
35employees
Non-managers
44employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
1 entities
CHUGAI PHARMABODY RESEARCH PTE. LTD.
Singapore
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CHUGAI PHARMABODY RESEARCH been operating for?
- What is the funding status of CHUGAI PHARMABODY RESEARCH?
- Where is CHUGAI PHARMABODY RESEARCH's headquarter?
- What CHUGAI PHARMABODY RESEARCH's spending power?
- Does CHUGAI PHARMABODY RESEARCH have a presence in the domain it operates in?